On the Mic with David Axelrod
In a follow up to their conversation during this year’s (virtual) Insurance Leadership Forum, Joel Wood, The Council’s SVP of Government Affairs, and national political analyst David Axelrod, discuss the incoming administration, what may come of the ACA, prospects of a public option, Medicare, prescription drug costs and more.
“It’ll be interesting to see how people feel about the pharmaceutical industry in the midst of these vaccines…Because the reality is that these are lifesaving drugs. The question is, what is reasonable? And because they are lifesaving drugs, to deprive people of them because they are so expensive, is essentially to deprive them of the chance to live. And that’s what makes this different.”